Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lingan Wang
Comment on “48-Week Outcome After Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors With Relapse”
Canadian Journal of Gastroenterology and Hepatology
Medicine
Hepatology
Gastroenterology
Related publications
Tenofovir Plus Entecavir Combination Therapy for Chronic Hepatitis B With Nucleos(t)ide Analogue Failure
The European Research Journal
Editorial: HBeAg Seroconversion Is Not Sufficient to Allow Cessation of Nucleos(t)ide Analogue Treatment in Caucasian Hepatitis B Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Combination Nucleos(t)ide Analogue as Initial Treatment for Chronic Hepatitis B: Have We Put This to Rest?
Hepatology
Medicine
Hepatology
Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso
Open Journal of Gastroenterology
Off-Treatment Virologic Relapse and Outcomes of Re-Treatment in Chronic Hepatitis B Patients Who Achieved Complete Viral Suppression With Oral Nucleos(t)ide Analogs
BMC Infectious Diseases
Infectious Diseases
Off-Treatment Efficacy of 3-Year Nucleos(t)ide Analogues in Chronic Hepatitis B Patients
Kaohsiung Journal of Medical Sciences
Medicine
Dynamics of Hepatitis B Virus Quasispecies Heterogeneity in Association With Nucleos(t)ide Analogue Treatment Determined by MALDI-TOF MS
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B
Current Hepatitis Reports
Factors Associated With Adherence to Nucleos(t)ide Analogs in Chronic Hepatitis B Patients: Results From a 1-Year Follow-Up Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
